Wed, Aug 20, 2014, 8:28 PM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Cadence Pharmaceuticals, Inc. Message Board

  • Shorterminator Shorterminator Apr 21, 2011 12:57 PM Flag

    Schroeder's Incline Directorship

    Cadence CEO Ted Schroeder is a director of Incline. In my opinion this is a positive for Cadence shareholders in terms of his access to information, including insight into the objectives of Incline's investors. The relationship between Cadence and Incline is "tight", but Schroeder's interests are clearly aligned with Cadence. This is true not only for his compensation, but also with respect to his responsibility/liability as an officer of a public company. I remain convinced that Cadence is in the driver's seat, and they will not overpay for Incline. If there is a selloff in the pps due to dilution, as stated by other posters, it will represent a buying opportunity.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
13.980.00(0.00%)Mar 18 4:00 PMEDT

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.